Efficacy and Safety of Basiliximab, Cyclosporine/Cyclosporine Microemulsion, and Steroids in Pediatric de Novo Liver Transplant Recipients Avoiding Intraoperative Steroids

Autores
Categoría Estudio primario
Registro de estudiosclinicaltrials.gov
Año 2004

Este artículo no está incluido en ninguna revisión sistemática

Cargando información sobre las referencias
Systemic infection is still a major concern in young children with liver transplantation. The approach of this study is to reduce the risk of systemic infections by avoiding intraoperative steroids (another class of immunosuppressive drugs) given in combination with basiliximab, cyclosporine and steroids in pediatric de novo liver transplant recipients. The treatment is compared to the same treatment regimen including intraoperative steroids with respect to rejection episodes.
Epistemonikos ID: 1dcee27093c5e6d3e3f7a7b530d795c4583f91bc
First added on: May 04, 2024